|
Spider
Biotech has a dynamic management team and a strong scientific
advisory board with a broad range of experience gained from both the
pharmaceutical industry and university.
Executive
Management
Andrea
Giuliani
Chief
Executive Officer and President (Co-founder)
Ph.D in Biotechnology at the Università di Siena, Italy. He
has
a consolidate experience in biochemistry, microbiology and peptide
based antiinfectives. Since the foundation of SpiderBiotech, Dr.
Giuliani held positions as Chief Executive Officer and President. Under
his leadership, SpiderBiotech developed a panel of novel peptide based
antiinfectives and exploited the full potential of this class of
molecules strenghtening the intellectual position of the
Company.
Giovanna
Pirri
Chief
Scientific Officer (Co-founder)
M.D. in Organic Chemistry and specialization in Polymer Science at the
Politecnico of Milano, Dr. Pirri was Senior Scientist at National
Council of Research and she has a consolidate knowledge in particular
in peptide chemistry, in polymer chemistry, and in the development of
analytical methodologies applied to diagnostics. She is a co-founder of
SpiderBiotech and she joined company as Chief Scientific Officer in
2007. She is author of several publications on international and
national journals, and contributions presented to international
conferences.
Luciano
Stabile
General
Counsel
Mr. Luciano Stabile is Vice President at Eporgen Venture S.p.A, Italy,
and has over 30 years of management experience in several companies
including Olivetti S.p.A., Olivetti U.S.A., FIAM S.r.l. and OMBI S.p.A.
Matteo Hary
General
Counsel
Mr Matteo Hary is CEO at Filatura di Trivero S.p.A. and holds a M.S. in
Engineering from the Politecnico di Torino.
The
Company's Scientific Advisory Board includes internationally
renowned scientists with expertise in immunology, peptide chemistry and
in commercial drug development.
Scientific
Advisory Board
Gianni
Garotta
Venture
Advisor at Index Ventures (Geneva, Switzerland)
Former investigator at the General Pathology Institute of the
University of Milan, the Wistar Institute, the Italian National Cancer
Institute (Milan, Italy) and the Basel Institute of Immunology. He was
the Head of the Cytokine and Monoclonal Antibody groups at Roche
(Basel, Switzerland) and the Head of Biology at Human Genome Sciences
(Rockville, MD, USA). Most recently, he was the Vice President of
Extramural Research and Academic Collaborations at Serono International
(Geneva, Switzerland). Dr Garotta has 25 year experience in discovery
and development of pharmaceutical and biological products and has been
involved in numerous academic and industrial collaborations.
|
People in
SpiderBiotech are Young,
Open
Minded and Passionate
for
Research.
|
